{"meshTagsMajor":["Genes, BRCA2","Genetic Predisposition to Disease"],"keywords":["BRCA2 gene","breast cancer","genetic counseling","male","mutation"],"meshTags":["Adult","Breast Neoplasms","Breast Neoplasms, Male","Codon, Nonsense","DNA Mutational Analysis","Genes, BRCA2","Genetic Predisposition to Disease","Humans","Male","Morocco","Treatment Outcome"],"meshMinor":["Adult","Breast Neoplasms","Breast Neoplasms, Male","Codon, Nonsense","DNA Mutational Analysis","Humans","Male","Morocco","Treatment Outcome"],"genes":["BRCA2 gene","BRCA1","BRCA2","BRCA2","BRCA1 germline","BRCA2 gene","BRCA2 gene","BRCA2 gene"],"organisms":["9606","9606","9606"],"publicationTypes":["Case Reports","Journal Article","Research Support, U.S. Gov\u0027t, Non-P.H.S."],"abstract":"Breast cancer is the most common cancer in women worldwide. About 5 to 10% of cases are due to an inherited predisposition in two major genes, BRCA1 and BRCA2, transmitted as an autosomal dominant form. Male breast cancer is rare and is mainly due to BRCA2 than BRCA1 germline mutations.\nMolecular study of BRCA2 gene in man with familial breast cancer.\nPCR and direct sequencing of BRCA2 gene.\nIdentification of novel heterozygous germline mutation c.6428C\u003eA ; p.Ser2143Stop of BRCA2 gene.","title":"Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancer.","pubmedId":"25320599"}